The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitors is a research paper published in Cell chemical biology (2021). On theSindex it has a DataRank of 1.4. It has been cited 38 times, with 35 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.550
From this paper's citation signal
Citation Network Contribution
0.893
From 29 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 35 citers.
NCI
Grant: R01 CA181746
NCI
Grant: / NCI R50 CA211447
NCI
Grant: P30-CA076292
NCI NIH HHS
Grant: R50 CA211447
NCI NIH HHS
Grant: P30 CA076292
National Institutes of Health
FWCI
2.44
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals